{"id":12795,"date":"2024-10-11T15:39:35","date_gmt":"2024-10-11T13:39:35","guid":{"rendered":"https:\/\/valintermed.com\/?p=12795"},"modified":"2024-10-11T15:39:35","modified_gmt":"2024-10-11T13:39:35","slug":"retikuloendotelioz","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/","title":{"rendered":"Reticuloendotheliosis"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Reticuloendotheliosis is a group of diseases characterized by the proliferation of cells of the reticuloendothelial system, which leads to dysfunction of organs and tissues. These diseases can manifest themselves in the form of various clinical symptoms, which makes diagnosis difficult. Establishing an accurate diagnosis depends on a combination of analytical data and examination results. Reticuloendotheliosis can be of both primary and secondary origin, depending on whether it is an independent disease or develops against the background of other pathologies. Effective treatment requires a comprehensive approach, including both pharmacological and non-drug methods.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/reticuloendotheliosis\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reticuloendotheliosis as a term was introduced into medical practice in the first half of the 20th century. In 1906, pathologists began actively studying the role of reticulocytes and other cells of the mononuclear phagocyte system in the pathogenesis of various diseases. Later, various variants of reticuloendotheliosis became known, including viral and non-infectious forms. It is interesting that at the stage of early research, doctors did not quite correctly interpret the interaction between the cells of the macrophage system and various infectious agents, which complicated diagnosis and treatment. The first successful attempts to classify diseases associated with reticuloendotheliosis were made in the 1960s, when scientists&#039; attention was focused on studying the effects of viruses on this system and its role in immune responses.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reticuloendotheliosis is generally a rare disease, but its prevalence may vary depending on geographic location and ecology. According to various medical studies, the incidence of this condition is 2-3 cases per 100,000 population per year. In most cases, reticuloendotheliosis is observed in patients aged 30 to 60 years, but cases are also possible in childhood. In clinical practice, it has been recorded that the disease occurs more often in men than in women. Socioeconomic factors, such as access to health care and the level of sanitation, can also affect the incidence rate.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Predisposition to reticuloendotheliosis may be associated with both hereditary factors and acquired mutations. To date, researchers have identified several genes involved in the pathogenesis of this disease. For example, disorders of genes responsible for the function of macrophages and other immune system cells may contribute to the development of the disease. The main genetic mutations associated with reticuloendotheliosis include:<\/p>\n<ul>\n<li>genes responsible for the regulation of apoptosis;<\/li>\n<li>genes associated with immune response;<\/li>\n<li>genes that regulate cell proliferation.<\/li>\n<\/ul>\n<p>Clinical studies confirm that the presence of certain gene variations in a risk group can increase the likelihood of developing recurrent forms of the disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>There are a number of factors that contribute to the development of reticuloendotheliosis, which can be divided into physical, chemical and other factors. These include:<\/p>\n<ul>\n<li>Occupational hazards such as long-term exposure to toxic chemicals, particularly industrial solvents;<\/li>\n<li>Infectious diseases that can promote activation of the immune system and cause proliferation of cells of the reticuloendothelial system;<\/li>\n<li>Environmental factors, including environmental pollution;<\/li>\n<li>History of immunodeficiency diseases such as HIV infection.<\/li>\n<\/ul>\n<p>It is also worth noting that the presence of concomitant diseases such as diabetes or hypertension may increase the risk of developing reticuloendotheliosis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of reticuloendotheliosis requires a comprehensive approach that includes both clinical and laboratory evaluation. The main symptoms of the disease may include:<\/p>\n<ul>\n<li>swollen lymph nodes.<\/li>\n<li>Fever and general malaise;<\/li>\n<li>Skin manifestations such as rash or exanthema;<\/li>\n<li>Symptoms of liver damage such as jaundice.<\/li>\n<\/ul>\n<p>Laboratory tests include:<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<ul>\n<li>Complete blood count to determine the presence of anemia, leukopenia, or thrombocytopenia;<\/li>\n<li>Biochemical blood test to assess liver and kidney function;<\/li>\n<li>Specific tests for infectious agents.<\/li>\n<\/ul>\n<p>Radiological examinations may include ultrasound, CT, and MRI to visualize the affected organs. Differential diagnosis should include conditions such as lymphoma and infectious diseases that lead to systemic inflammatory syndromes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of reticuloendotheliosis depends on the form of the disease and its causes. In general, therapy can be drug-based, surgical, and includes alternative treatment methods.<\/p>\n<ul>\n<li>Pharmacological treatment may include glucocorticosteroids, immunomodulators, and chemotherapy drugs;<\/li>\n<li>In cases requiring surgical treatment, surgical interventions can be performed to remove altered tissues;<\/li>\n<li>Physiotherapy and rehabilitation methods are used in parallel;<\/li>\n<li>If infectious agents are present, antibiotics or antiviral agents may be prescribed.<\/li>\n<\/ul>\n<p>It should be noted that treatment should be individualized depending on the clinical situation and concomitant diseases.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the drugs that can be used to treat reticuloendotheliosis are:<\/p>\n<ul>\n<li>Prednisolone (a glucocorticosteroid for anti-inflammatory therapy);<\/li>\n<li>Azathioprine (immunosuppressant);<\/li>\n<li>Doxorubicin (a chemotherapeutic agent used in cases of malignant processes);<\/li>\n<li>Clozapine (possibly used as an adjuvant drug in second-line therapy).<\/li>\n<\/ul>\n<p>The choice of drugs is based on clinical recommendations and individual characteristics of the patient.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of the patient&#039;s condition with reticuloendotheliosis includes regular examinations and assessments of clinical dynamics. The main control stages are:<\/p>\n<ul>\n<li>Constant monitoring of blood parameters;<\/li>\n<li>Repeated laboratory and radiological studies to evaluate therapy;<\/li>\n<li>Evaluation of possible complications, including disease progression.<\/li>\n<\/ul>\n<p>The prognosis depends on the form and activity of the disease, as well as the adequacy of the treatment. Complications may include the development of sluggish infections and organ failure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reticuloendotheliosis may manifest itself differently depending on the patient&#039;s age group. In early childhood, the disease may be more aggressive, due to an underdeveloped immune system. In older people, the disease is usually more chronic and has concomitant diseases, which significantly complicates diagnosis and treatment.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What are the main symptoms of reticuloendotheliosis?<\/strong> The main symptoms are enlarged lymph nodes, fever, general malaise, skin manifestations and symptoms of liver damage.<\/li>\n<li><strong>Who is at risk for developing reticuloendotheliosis?<\/strong> Those at risk include patients with occupational hazards, infectious diseases, and people with health conditions such as diabetes.<\/li>\n<li><strong>How is reticuloendotheliosis diagnosed?<\/strong> Diagnosis includes clinical tests, biochemical tests, radiological studies and differential diagnosis with other diseases.<\/li>\n<li><strong>What is the treatment for reticuloendotheliosis?<\/strong> Treatment may include pharmacological therapy (glucocorticosteroids, chemotherapy drugs), surgery, and alternative treatments.<\/li>\n<li><strong>What is the risk of complications with reticuloendotheliosis?<\/strong> The likelihood of complications depends on the form of the disease, the adequacy of treatment and the presence of concomitant diseases.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Reticuloendotheliosis is a group of diseases characterized by the proliferation of cells of the reticuloendothelial system, which leads to dysfunction of organs and tissues. These diseases<\/p>","protected":false},"author":1,"featured_media":22601,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-12795","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=12795"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12795\/revisions"}],"predecessor-version":[{"id":14286,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12795\/revisions\/14286"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/22601"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=12795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=12795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=12795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}